UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Melanoma Targeted Therapies beyond BRAF-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches

Cancers, 2021-11, Vol.13 (22), p.5847

2021

Volltextzugriff (PDF)

Class III β-tubulin expression as a predictor of docetaxel-resistance in metastatic castration-resistant prostate cancer

PloS one, 2019-10, Vol.14 (10), p.e0222510-e0222510

2019

Volltextzugriff (PDF)

Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy

BMC cancer, 2022-06, Vol.22 (1), p.626-626, Article 626

2022

Volltextzugriff (PDF)

Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropenia

Journal of oncology pharmacy practice, 2022-01, Vol.28 (1), p.17-23

2022

Volltextzugriff (PDF)

Parotid gland tumors: a retrospective study of 154 patients

Brazilian journal of otorhinolaryngology, 2015-05, Vol.81 (3), p.301-306

2015

Volltextzugriff (PDF)

A Case of Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis

Case Reports in Hepatology, 2020-08, Vol.2020, p.1-4

2020

Volltextzugriff (PDF)

Molecular features and race‐associated outcomes of SPOP‐mutant metastatic castration‐resistant prostate cancer

The Prostate, 2023-05, Vol.83 (6), p.524-533

2023

Volltextzugriff (PDF)

High dose total marrow irradiation (TMI) does not increase long‐term toxicity of myeloablative fludarabine/busulfan (FluBu4) conditioning regimen in allogeneic hematopoietic stem cell transplantation (HSCT)

European journal of haematology, 2024-07, Vol.113 (1), p.110-116

2024

Volltextzugriff (PDF)

Therapeutic Use of Carbon Monoxide in Ex-Vivo Lung Perfusion in Donor With Prolonged Cold Ischemia

The Journal of surgical research, 2024-09, Vol.301, p.315-323

2024

Volltextzugriff (PDF)

Long-Term Adverse Events of Total Marrow Irradiation (TMI)-Based Conditioning Chemotherapy in Hematopoietic Stem Cell Transplant Recipients Treated on a Phase I/II Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.12913-12914

2022

Volltextzugriff (PDF)

G-CSF Improves Stable Engraftment in Adults with Sickle Cell Disease Undergoing Nonmyeloablative Hematopoietic Stem Cell Transplantation

Blood, 2022-11, Vol.140 (Supplement 1), p.4747-4748

2022

Volltextzugriff (PDF)

SPOP mutation as a predictive marker for treatment of metastatic castration-resistant prostate cancer

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.160-160

2021

Volltextzugriff (PDF)

Cetuximab and Anemia Prevention in Head and Neck Cancer Patients Undergoing Radiotherapy

Blood, 2020-11, Vol.136 (Supplement 1), p.7-8

2020

Volltextzugriff (PDF)

Pegfilgrastim on-body injector: Post-market performance analysis

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19226-e19226

2020

Volltextzugriff (PDF)

Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation

The Journal of heart and lung transplantation, 2016-10, Vol.35 (10), p.1245-1254

2016

Volltextzugriff (PDF)

Chronic Opioid Use Is Highly Prevalent and Associated with Inferior Survival in Myeloma Patients in Remission after Autologous Transplant

Blood, 2022-11, Vol.140 (Supplement 1), p.5252-5253

2022

Volltextzugriff (PDF)

Class III [beta]-tubulin expression as a predictor of docetaxel-resistance in metastatic castration-resistant prostate cancer

PloS one, 2019-10, Vol.14 (10), p.e0222510

2019

Volltextzugriff (PDF)

Lung lavage and surfactant replacement during ex vivo lung perfusion for treatment of gastric acid aspiration-induced donor lung injury

The Journal of heart and lung transplantation, 2017-05, Vol.36 (5), p.577-585

2017

Volltextzugriff (PDF)

High Dose Total Marrow Irradiation (TMI) Does Not Increase the Risk of Long-Term Toxicity to Myeloablative Fludarabine/Busulfan Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S364-S365

2023

Volltextzugriff (PDF)

485 - High Dose Total Marrow Irradiation (TMI) Does Not Increase the Risk of Long-Term Toxicity to Myeloablative Fludarabine/Busulfan Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S364-S365

2023

Volltextzugriff (PDF)

Addition of Myeloablative Doses of Total Marrow Irradiation (TMI) to Myeloablative Fludarabine/Busulfan Conditioning for Allogeneic HSCT in Patients with High-Risk AML, CML, or Myelodysplastic Syndrome: A Phase II Clinical Trial

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S162-S163

2024

Volltextzugriff (PDF)

Chronic Opioid Use Is Associated with Inferior Survival in Myeloma Patients Undergoing Autologous Transplant

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S44

2023

Volltextzugriff (PDF)

51 - Chronic Opioid Use Is Associated with Inferior Survival in Myeloma Patients Undergoing Autologous Transplant

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S44-S44

2023

Volltextzugriff (PDF)

Challenges and Results of Haploidentical Stem Cell Transplantation for Adult Patients in Cuba

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S302-S303

2023

Volltextzugriff (PDF)

400 - Challenges and Results of Haploidentical Stem Cell Transplantation for Adult Patients in Cuba

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S302-S303

2023

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(30)
Berichte
(1)

Sprache

Englisch
(31)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Melanoma Targeted Therapies beyond BRAF-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches

Class III β-tubulin expression as a predictor of docetaxel-resistance in metastatic castration-resistant prostate cancer

Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy

Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropenia

Parotid gland tumors: a retrospective study of 154 patients

A Case of Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis

Molecular features and race‐associated outcomes of SPOP‐mutant metastatic castration‐resistant prostate cancer

High dose total marrow irradiation (TMI) does not increase long‐term toxicity of myeloablative fludarabine/busulfan (FluBu4) conditioning regimen in allogeneic hematopoietic stem cell transplantation (HSCT)

Therapeutic Use of Carbon Monoxide in Ex-Vivo Lung Perfusion in Donor With Prolonged Cold Ischemia

Long-Term Adverse Events of Total Marrow Irradiation (TMI)-Based Conditioning Chemotherapy in Hematopoietic Stem Cell Transplant Recipients Treated on a Phase I/II Trial

G-CSF Improves Stable Engraftment in Adults with Sickle Cell Disease Undergoing Nonmyeloablative Hematopoietic Stem Cell Transplantation

SPOP mutation as a predictive marker for treatment of metastatic castration-resistant prostate cancer

Cetuximab and Anemia Prevention in Head and Neck Cancer Patients Undergoing Radiotherapy

Pegfilgrastim on-body injector: Post-market performance analysis

Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation

Chronic Opioid Use Is Highly Prevalent and Associated with Inferior Survival in Myeloma Patients in Remission after Autologous Transplant

Class III [beta]-tubulin expression as a predictor of docetaxel-resistance in metastatic castration-resistant prostate cancer

Lung lavage and surfactant replacement during ex vivo lung perfusion for treatment of gastric acid aspiration-induced donor lung injury

High Dose Total Marrow Irradiation (TMI) Does Not Increase the Risk of Long-Term Toxicity to Myeloablative Fludarabine/Busulfan Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

485 - High Dose Total Marrow Irradiation (TMI) Does Not Increase the Risk of Long-Term Toxicity to Myeloablative Fludarabine/Busulfan Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Addition of Myeloablative Doses of Total Marrow Irradiation (TMI) to Myeloablative Fludarabine/Busulfan Conditioning for Allogeneic HSCT in Patients with High-Risk AML, CML, or Myelodysplastic Syndrome: A Phase II Clinical Trial

Chronic Opioid Use Is Associated with Inferior Survival in Myeloma Patients Undergoing Autologous Transplant

51 - Chronic Opioid Use Is Associated with Inferior Survival in Myeloma Patients Undergoing Autologous Transplant

Challenges and Results of Haploidentical Stem Cell Transplantation for Adult Patients in Cuba

400 - Challenges and Results of Haploidentical Stem Cell Transplantation for Adult Patients in Cuba

Suchergebnisse filtern